• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

美国 2018 年癌症筛查：对当前美国癌症协会指南和癌症筛查中当前问题的综述。

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.

机构信息

Vice President, Cancer Screening, Cancer Control Department, American Cancer Society, Atlanta, GA.

Director, Guidelines Process, Cancer Control Department, American Cancer Society, Atlanta, GA.

出版信息

CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446. Epub 2018 May 30.

DOI:10.3322/caac.21446
PMID:29846940
Abstract

Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates from the National Health Interview Survey, and select issues related to cancer screening. In this 2018 update, we also summarize the new American Cancer Society colorectal cancer screening guideline and include a clarification in the language of the 2013 lung cancer screening guideline. CA Cancer J Clin 2018;68:297-316. © 2018 American Cancer Society.

摘要

每年，美国癌症协会都会发布一份早期癌症检测指南摘要，以及来自国家健康访谈调查的癌症筛查率数据和趋势，和一些与癌症筛查相关的精选问题。在本次 2018 年的更新中，我们还总结了美国癌症协会新的结直肠癌筛查指南，并在 2013 年肺癌筛查指南的语言中加入了一项澄清。CA Cancer J Clin 2018;68:297-316。© 2018 美国癌症协会。

相似文献

1
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2018 年癌症筛查：对当前美国癌症协会指南和癌症筛查中当前问题的综述。
CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446. Epub 2018 May 30.
2
Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2017 年癌症筛查：对当前美国癌症协会指南和癌症筛查当前问题的回顾。
CA Cancer J Clin. 2017 Mar;67(2):100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7.
3
Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2019 年癌症筛查：对当前美国癌症协会指南和癌症筛查中当前问题的回顾。
CA Cancer J Clin. 2019 May;69(3):184-210. doi: 10.3322/caac.21557. Epub 2019 Mar 15.
4
Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening.美国 2014 年癌症筛查：对当前美国癌症协会指南和癌症筛查当前问题的回顾。
CA Cancer J Clin. 2014 Jan-Feb;64(1):30-51. doi: 10.3322/caac.21212. Epub 2014 Jan 9.
5
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.美国 2013 年癌症筛查：对当前美国癌症协会指南、癌症筛查当前问题以及宫颈癌筛查和肺癌筛查新指南的回顾。
CA Cancer J Clin. 2013 Mar-Apr;63(2):88-105. doi: 10.3322/caac.21174. Epub 2013 Feb 1.
6
Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2016 年癌症筛查：对当前美国癌症协会指南和癌症筛查当前问题的回顾。
CA Cancer J Clin. 2016 Mar-Apr;66(2):96-114. doi: 10.3322/caac.21336. Epub 2016 Jan 21.
7
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.美国 2010 年癌症筛查：对现行美国癌症协会指南的回顾以及癌症筛查中的问题。
CA Cancer J Clin. 2010 Mar-Apr;60(2):99-119. doi: 10.3322/caac.20063.
8
Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening.美国癌症筛查 2012：对当前美国癌症协会指南及癌症筛查当前问题的回顾。
CA Cancer J Clin. 2012 Mar-Apr;62(2):129-42. doi: 10.3322/caac.20143. Epub 2012 Jan 19.
9
Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues.2008年美国的癌症筛查：美国癌症协会现行指南及癌症筛查问题综述
CA Cancer J Clin. 2008 May-Jun;58(3):161-79. doi: 10.3322/CA.2007.0017. Epub 2008 Apr 28.
10
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.2009年美国癌症筛查：美国癌症协会当前指南及癌症筛查问题综述
CA Cancer J Clin. 2009 Jan-Feb;59(1):27-41. doi: 10.3322/caac.20008.

引用本文的文献

1
Association of anthropometric indices with rs9939609 gene polymorphism among overweight/obese women with breast cancer: a case-control study.超重/肥胖乳腺癌女性人体测量指数与rs9939609基因多态性的关联：一项病例对照研究。
Front Nutr. 2025 Jun 24;12:1548340. doi: 10.3389/fnut.2025.1548340. eCollection 2025.
2
Breast Cancer in Afghan Women: A Systematic Review of Awareness, Screening Practices, and Risk Factors.阿富汗女性乳腺癌：意识、筛查实践及风险因素的系统评价
J Epidemiol Glob Health. 2025 Jul 2;15(1):91. doi: 10.1007/s44197-025-00427-5.
3
Prostate Cancer Screening Decisions: Which Aspects Do Men Value Most? An Interview Study With Men Invited to a Population-Based Program.
前列腺癌筛查决策：男性最看重哪些方面？一项针对受邀参加基于人群项目的男性的访谈研究。
Am J Mens Health. 2025 May-Jun;19(3):15579883251344563. doi: 10.1177/15579883251344563. Epub 2025 Jun 23.
4
Expression and clinical value of EIF3CL in serous ovarian cancer.EIF3CL在浆液性卵巢癌中的表达及临床价值
J Int Med Res. 2025 May;53(5):3000605251340320. doi: 10.1177/03000605251340320. Epub 2025 May 26.
5
Who is the Candidate? The Heart Transplant Evaluation Process.谁是候选人？心脏移植评估过程。
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):13-24. doi: 10.14797/mdcvj.1512. eCollection 2025.
6
PSAT1 regulated by STAT4 enhances the proliferation, invasion and migration of ovarian cancer cells via the PI3K/AKT pathway.由信号转导和转录激活因子4（STAT4）调控的脯氨酸富积酸性蛋白1（PSAT1）通过磷脂酰肌醇-3激酶/蛋白激酶B（PI3K/AKT）途径增强卵巢癌细胞的增殖、侵袭和迁移能力。
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5529. Epub 2025 Apr 11.
7
Determinants and barriers to women's participation in breast cancer screening activities in Jordan: an in-depth study.约旦女性参与乳腺癌筛查活动的决定因素与障碍：一项深入研究
BMC Public Health. 2025 Apr 10;25(1):1339. doi: 10.1186/s12889-025-22611-9.
8
Knowledge and perception of cancer screening tests among Indian community.印度社区对癌症筛查检测的认知与了解
Bioinformation. 2024 Nov 30;20(11):1635-1640. doi: 10.6026/9732063002001635. eCollection 2024.
9
DUSP4 inhibited tumor cell proliferation by downregulating glycolysis via p-ERK/p-PGK1 signaling in ovarian cancer.双特异性磷酸酶4（DUSP4）通过p-ERK/p-磷酸甘油酸激酶1（p-PGK1）信号通路下调糖酵解，从而抑制卵巢癌细胞增殖。
Cancer Cell Int. 2025 Mar 13;25(1):87. doi: 10.1186/s12935-025-03722-0.
10
Progress and prospects of the combination of BMI1-targeted therapy and immunotherapy in cervical cancer.BMI1靶向治疗与免疫治疗联合应用于宫颈癌的研究进展与展望
Am J Cancer Res. 2025 Jan 15;15(1):217-232. doi: 10.62347/QTWJ8918. eCollection 2025.